Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Animal models of NAFLD from a hepatologist's point of view
Daniel Jahn, Stefan Kircher, Heike M. Hermanns, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1865, Iss. 5, pp. 943-953
Open Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice
Qian Ye, Yi Liu, Guiji Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 68
Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy
Peng Cao, Yì Wáng, Cong Zhang, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 120, pp. 109414-109414
Closed Access | Times Cited: 47
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
Clémence Rives, Anne Fougerat, Sandrine Ellero‐Simatos, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1702-1702
Open Access | Times Cited: 116
From the origin of NASH to the future of metabolic fatty liver disease
Andreas Geier, Dina Tiniakos, Helmut Denk, et al.
Gut (2021) Vol. 70, Iss. 8, pp. 1570-1579
Open Access | Times Cited: 59
Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
Ronan Thibaut, Matthew Gage, Inés Pineda‐Torra, et al.
FEBS Journal (2021) Vol. 289, Iss. 11, pp. 3024-3057
Open Access | Times Cited: 55
Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2
Boushra Bathish, Holly Robertson, John Dillon, et al.
Free Radical Biology and Medicine (2022) Vol. 188, pp. 221-261
Open Access | Times Cited: 50
Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease
Qiannan Ren, Qiming Sun, Junfen Fu
Autophagy (2023) Vol. 20, Iss. 2, pp. 221-241
Open Access | Times Cited: 37
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake
Kexin Nie, Yang Gao, Shen Chen, et al.
Phytomedicine (2023) Vol. 111, pp. 154661-154661
Open Access | Times Cited: 23
Inulin-enriched Megamonas funiformis ameliorates metabolic dysfunction-associated fatty liver disease by producing propionic acid
Xinyue Yang, Meihong Zhang, Yan Liu, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Semaglutide alters gut microbiota and improves NAFLD in db/db mice
Tuohua Mao, Chenxuan Zhang, Shuang Yang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 710, pp. 149882-149882
Closed Access | Times Cited: 11
Phocaeicola vulgatus alleviates diet-induced metabolic dysfunction-associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA
Shengxi Jin, Peng Chen, Jing Yang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Transcriptomics-driven metabolic pathway analysis reveals similar alterations in lipid metabolism in mouse MASH model and human
Sofia Tsouka, Pavitra Kumar, Patcharamon Seubnooch, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 9
NAFLD Preclinical Models: More than a Handful, Less of a Concern?
Yvonne Oligschlaeger, Ronit Shiri‐Sverdlov
Biomedicines (2020) Vol. 8, Iss. 2, pp. 28-28
Open Access | Times Cited: 55
Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice
Kyoko Yamazaki, Tamotsu Kato, Yuuri Tsuboi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
Siyu Yu, Chunlin Li, Guang Ji, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
Salvatore Pezzino, Maria Sofia, Gloria Faletra, et al.
Biology (2022) Vol. 11, Iss. 11, pp. 1622-1622
Open Access | Times Cited: 31
Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease
Jiashu Pan, Wenjun Zhou, Ruohui Xu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113127-113127
Open Access | Times Cited: 28
Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway
Yiping Li, Yang Liu, Zhiwei Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114319-114319
Open Access | Times Cited: 16
Probiotic yogurt regulates gut microbiota homeostasis and alleviates hepatic steatosis and liver injury induced by high‐fat diet in golden hamsters
Linwensi Zhu, Na Ying, Liuyi Hao, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 4, pp. 2488-2501
Open Access | Times Cited: 6
Strategies for Decontamination and Alleviation of Mycotoxins for Sustainable Poultry Farming – A Review
Youssef A. Attia, Tarek A. Ebeid, Manal E. Shafi, et al.
Annals of Animal Science (2025) Vol. 25, Iss. 1, pp. 139-157
Open Access
Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress
Sarayu Pai, Renuka Munshi, Falguni Panchal, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 686-694
Open Access | Times Cited: 53
Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles
Alejandra Hernández, Yana Geng, Rolando Sepúlveda, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 6, pp. 165753-165753
Open Access | Times Cited: 47
Role of Angiogenesis in the Pathogenesis of NAFLD
Lin Lei, Haquima El Mourabit, Chantal Housset, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1338-1338
Open Access | Times Cited: 34
Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics
Rhema Khairnar, Md Asrarul Islam, Joshua S. Fleishman, et al.
Life Sciences (2022) Vol. 312, pp. 121185-121185
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top